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Serologic Evidence 
of Pandemic (H1N1) 
2009 Infection in 
Dogs, Italy 
To the Editor: Until recently, the 
general consensus has been that dogs 
are poorly susceptible to natural infec-
tion with infl uenza A viruses; however, 
since the recent upsurge of infl uenza A 
circulating subtypes H5N1 and H1N1 
viruses, cases of natural infection in 
dogs have apparently increased. Thus, 
the role of these animals is being re-
considered in the transmission and 
spread of infl uenza viruses (1–3).
In April 2009, the most recent 
of the human infl uenza A pandemics, 
pandemic (H1N1) 2009, was detected 
in Mexico. The virus rapidly spread 
worldwide, within weeks of its fi rst 
isolation. To date, pandemic (H1N1) 
2009 has primarily infected humans, 
although transmission from infected 
humans to other animals, including 
pigs, turkeys, ferrets, cats, and dogs 
has been reported (4,5).
In Italy (population ≈58 million), 
the fi rst human cases of pandemic 
(H1N1) 2009 were reported in May 
2009; confi rmed cases peaked during 
the second week of November 2009 
(week 46) (6). As of May 9, 2010, Italy 
had recorded an estimated 5,582,000 
cases of pandemic (H1N1) 2009. In It-
aly as well, the population has ≈7 mil-
lion companion dogs and ≈7.5 million 
cats (7). Because of the close contact 
between persons and their companion 
animals, we initiated this serologic 
study to determine whether evidence 
of pandemic (H1N1) 2009 transmis-
sion could be found in companion ani-
mals in Italy.
We tested serum specimens 
from dogs (n = 964) and cats (n = 
97), originally submitted to the Is-
tituto Zooprofi lattico Sperimentale 
delle Venezie in Legnaro, Italy, from 
October through December 2009 
(weeks 41–53), for assessment of ra-
bies vaccine effi cacy. An average of 
70 samples were tested per week; the 
highest number of samples (n = 106) 
was tested for week 51 and the low-
est (n = 25) for week 53. Testing for 
antibody to infl uenza A nucleoprotein 
was performed by using a commer-
cially available competitive ELISA 
(cELISA) (ID Screen Infl uenza A 
Antibody Competition Assay; ID Vet, 
Montpellier, France), according to 
the manufacturer’s instructions. Pre-
vious work from our laboratory has 
assigned a sensitivity of 93.98% and 
specifi city of 98.71% to this cELISA 
for the testing of canine serum sam-
ples (8). In total, 29 serum specimens 
tested at a 1:10 dilution, all from 
dogs, were positive after a second 
confi rmatory screening. None of the 
97 feline serum samples were posi-
tive by cELISA.
The cELISA-positive serum spec-
imens were then treated with receptor-
destroying enzyme (RDE; Sigma-
Aldrich, St. Louis, MO, USA) (1 part 
serum: 3 parts RDE) for 16 h at 37°C, 
followed by heat inactivation at 56°C 
for 30 min. We then tested the speci-
mens by the hemagglutination inhibi-
tion (HI) test against the pandemic vi-
rus A/Verona/Italy/2810/2009 (H1N1), 
A/swine/Italy/711/2006 (H1N1), and 
H3N8 (A/canine/Florida/2004) by 
using 0.5% chicken erythrocytes and 
standard methods (9). Seven serum 
samples (nos. 4410, 4438, 4444, 4460, 
4517, 4520, 4681) were positive by HI 
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to A/Verona/Italy/2810/2009 (H1N1) 
with titers ranging from 16 to 256 
(Table), but not for the other viruses, 
although the samples with the higher 
titers of 256 (nos. 4460 and 4681) 
against A/Verona/Italy/2810/2009 also 
cross-reacted with antigen A/swine/
Italy/711/2006 (H1N1) (titers 16 and 
32, respectively).
The HI-positive serum speci-
mens were later tested in a microneu-
tralization assay with A/Verona/
Italy/2810/2009 (H1N1). Suppres-
sion of virus antigen expression was 
assessed by an ELISA assay as end-
point by using a slight modifi cation 
of a previously described procedure 
(10). As can be seen from the Table, 
all 7 serum specimens positive by HI 
for A/Verona/Italy/2810/09 inhibited 
infection of MDCK cells by the same 
virus at dilutions of 1:160 or higher, 
confi rming the presence of anti-H1 
antibodies.
To summarize, in this study, 
1,061 serum specimens from com-
panion dogs and cats collected dur-
ing the circulation peak of pandemic 
(H1N1) 2009 in Italy were screened 
with 7 (0.7%) of the canine serum 
specimens showing evidence of ex-
posure to the virus. Notably, the posi-
tive samples were collected during 
the period (weeks 43–45) that almost 
coincided with the reported peak for 
human cases of pandemic (H1N1) 
2009 in Italy (week 46). Totals of 
69, 77, and 56 samples were col-
lected during weeks 43, 44, and 45, 
respectively, which indicates that the 
sample group had no bias. 
The data thus suggest that trans-
mission occurred, most probably by 
aerosol or close contact, between pan-
demic (H1N1) 2009–infected owners 
and their pets during this peak period 
of mid-November 2009. How long 
these animals were infected, whether 
the infection had clinical manifesta-
tions, and whether the dogs were ca-
pable of transmitting the virus to other 
hosts are all questions that remain 
unanswered. However, on the basis 
of the low number of positive speci-
mens identifi ed in this study, it would 
be unrealistic to suggest that dogs are 
particularly susceptible to pandemic 
(H1N1) 2009. Nevertheless, as has 
been seen with infection of dogs with 
subtype H3N8, infl uenza A viruses 
are quite capable of evolving and be-
coming more host specifi c. This fac-
tor alone would justify the continued 
surveillance of infl uenza A viruses in 
domestic dogs.
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Table. Anagraphic data and HI and MN titers of canine serum specimens against A/Verona/Italy/2810/2009 (H1N1), 2009* 
Sample 
no. Species Birth date Sample origin, Italy Coordinates 
Sample 
date/wk HI MN 
4410 English setter 2005 Jun 5 Mercato Saraceno 43°57 0 N,12°12 0 E Nov 24/43 32 640 
4438 Labrador retriever 2005 Oct10 Casale Monferrato 45°8 3 N, 8°27 30 E Nov 26/44 32 160 
4444 Chihuahua 2008 Apr 7 Mantaova 45°10 0 N, 10°48 0 E Nov 30/44 16 160 
4460 Small cross-breed 2005 Jan 20 Milano 45°27 50.98 N, 9°11 25.21 E Nov 30/44 256 >2,560 
4517 Italian Segugio 2007 Jul 4 Giussano 45°42 0 N, 9°13 0 E Nov 30/44 128 640 
4520 Shih tzu 2007 Dec 8 Peschiera del Garda 45°26 0 N, 10°41 0 E Dec 2/46 64 320 
4618 Yorkshire terrier 2008 Dec 21 Garda 45°34 0 N, 10°43 0 E Dec 9/45 256 >2,560 
*HI, hemagglutination inhibition; MN, microneutralization. 
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To the Editor: Approximately 
10% of patients with brucellosis expe-
rience a relapse, 90% of which occur 
within a year after discontinuation of 
antimicrobial drug therapy (1,2). Here 
we report a patient who had brucel-
losis in a disease-endemic area, im-
migrated to a brucellosis-free region, 
and experienced focal reactivation in 
her gallbladder 28 years later. To our 
knowledge, this interval is among the 
longest reported asymptomatic inter-
vals between a fi rst brucellosis episode 
and reactivation. The case suggests 
that physicians should not disregard 
remote histories of brucellosis and 
past residence in brucellosis-endemic 
areas when confronted with possible 
reactivation disease.
A woman, born in 1955, had pro-
longed fever without focal symptoms 
in 1981 and had received a diagnosis of 
brucellosis while living near Valencia, 
Spain. The brucellosis was attributed 
to an episode of eating unpasteurized 
cheese from the local dairy and was 
successfully treated. She immigrated 
to Switzerland in 1990 and was well 
until March 2009, when malaise and 
right upper quadrant pain developed, 
without fever. She was otherwise 
healthy and did not take any medi-
cation. Computed tomography (CT) 
scan showed a mass contiguous with 
the gallbladder, extending intrahe-
patically, with concentric calcifi ca-
tions and multiple gallstones (Figure). 
Gallbladder cancer was suspected, but 
when a laparotomy was performed, 
an acutely infl amed gallbladder with 
a surrounding infl ammatory mass was 
found and excised. Gallbladder cul-
tures on standard media (Columbia 
agar with 5% sheep’s blood, chocolate 
agar, Brucella blood agar, and brain-
heart infusion broth) were discarded 
when they remained sterile after 5 
days of incubation. Histopathologic 
examination showed granulomatous 
cholecystitis, and the patient was re-
ferred for infectious disease consulta-
tion. Formalin-fi xed gallbladder tis-
sue was negative for Mycobacterium 
tuberculosis complex DNA but posi-
tive for Brucella melitensis by PCR 
(3). Blood cultures (BACTEC Plus 
Aerobic/F and Anaerobic/F [Becton 
Dickinson, Allschwil, Switzerland], 
incubated for 10 days) remained ster-
ile. No Brucella DNA was detected 
in blood and serum (1,2), and a rose 
bengal serum agglutination test was 
negative for anti-Brucella antibodies. 
Because of the rarity of the manifes-
tation (late reactivation) and location 
(gallbladder), plus a residual abscess 
shown on CT scan 8 weeks after sur-
gery, prolonged treatment with doxy-
cycline and rifampin was adminis-
tered for 3 months, with gentamicin 
added during the initial 2 weeks (4). 
Nine months after antimicrobial drug 
therapy was discontinued, the patient 
remains well.
Switzerland reported the elimina-
tion of animal brucellosis in 1963 (5) 
and has offi cially been brucellosis-free 
since 1998, according to article 14.1.2. 
of the Terrestrial Animal Health Code 
(www.oie.int/eng/normes/mcode/
en_chapitre_1.14.1.htm). The last 
case of B. melitensis infection in a 
sheep or goat in Switzerland was re-
ported in 1985. The annual number of 
human brucellosis cases reported in 
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Figure. A) Contrast-enhanced computerized tomography (CT) scan showing a calcifi ed 
gallbladder wall (arrow), a surrounding, calcifi ed mass located peripherally in the liver, 
and an abscess in the adjacent fat tissue (arrowhead). B) T2-weighted axial magnetic 
resonance imaging shows multiple gallstones and a thickened gallbladder wall (arrow), 
infl ammation and edema of the adjacent liver, fat tissue, and proximal duodenum. C) Eight 
weeks after cholecystectomy, contrast-enhanced CT shows a residual abscess in the 
adjacent fat tissue (arrowhead). D) Contrast-enhanced CT 5 months after cholecystectomy 
shows only minimal changes in the gallbladder bed and surrounding tissues, and no 
residual abscess.
